Here you will find the latest information about the APONTIS PHARMA share as well as current share price data.

APONTIS PHARMA on the capital market

Share Price
Analysts
Latest update Institution Analyst Recommendation Price target (EUR) Download
24/08/2021 EDISON Dr. Sean Conroy
Dr. Jonas Peciulis
* *
09/03/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 35.00 (41.00)
10/03/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30.00 (32.00)
07/04/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 33.00 (35.00)
19/04/2022 Montega Research Henrik Markmann BUY (BUY) 26.00 Download Here
11/05/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 31.00 (33.00)
11/05/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30.00 (30.00)
11/05/2022 Montega Research Henrik Markmann BUY (BUY) 26.00 (26.00) Download Here
30/05/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30.00 (30.00) Download Here
28/06/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 31.00 (31.00) Download Here
11/08/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 31.00 (31.00) Download Here
12/08/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 29.00 (31.00) Download Here
12/08/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30.00 (30.00) Download Here
16/08/2022 Montega Research Tim Kruse BUY (BUY) 26.00 (26.00) Download Here

* Qualitative analysis without price target / recommendation (Scale)

Share Information

Company fundamentals

 

First day of trading

11 May 2021

Issue price

EUR 19.00

Ticker symbol

APPH

ISIN (International
Securities Identification Number)

DE000A3CMGM5

WKN (German Securities Code)

A3CMGM

LEI (Legal Entity Identifier)

894500ETO1J6MR8PDF91

Stock Exchange and trading venue

Frankfurt Stock Exchange/Xetra

Trading Segment

Scale (Open Market)

Total Number Of Shares

8,500,000

Share Capital

EUR 8,500,000.00

Type of share

Ordinary bearer shares without nominal value (no-par shares)

Designated Sponsor

Hauck & Aufhäuser Privatbankiers AG

Specialist

Bankhaus Scheich Wertpapierspezialist AG

Paying Agent

Bankhaus Gebr. Martin AG

  • Download Company Profile

INITIAL PUBLIC OFFERING

Here you can find all relevant information about the successful IPO of APONTIS PHARMA AG.


IPO INFORMATION
CONTACT INVESTOR RELATIONS

I look forward to your message

Do not miss any publications or news about APONTIS PHARMA AG. By registering for our IR mailings, you will always stay informed.